UCB To Acquire Candid Therapeutics For Up To $2.2 Billion - Pulse 2.0
UCB→Candid Therapeutics
May 4, 2026
Monument Health has completed the acquisition of Rapid City Medical Center, a healthcare services other business in South Dakota. The Rapid City Medical Center acquisition expands Monument Health’s community health system footprint in Rapid City and supports continuity of care for existing patients and providers. Monument Health acquisitions in healthcare M&A aim to broaden clinical resources and services available to the region. The merger acquisition was announced as a strategic acquisition after a letter of intent signed in late January, with the integration effective May 1; deal size was undisclosed.
Source
Read full article on beckershospitalreview.comvia Becker's Hospital Review — All · May 1, 2026
UCB→Candid Therapeutics
May 4, 2026
UCB→Candid Therapeutics
May 3, 2026
Pennant→Senior Living Communities
May 1, 2026
PharmaCorp Rx
May 1, 2026
Legacy Therapeutics→Cansortium Texas
May 1, 2026